Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.905 USD | +2.97% | +6.15% | 0.00% |
18/04 | Verastem Names John Hayslip as Chief Medical Officer | MT |
15/04 | I-Mab Announces Chief Medical Officer Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
0.00% | 15Cr | |
+31.69% | 59TCr | |
-3.20% | 36TCr | |
+19.54% | 33TCr | |
+5.07% | 29TCr | |
+15.55% | 24TCr | |
+10.18% | 21TCr | |
-7.20% | 20TCr | |
+8.95% | 17TCr | |
-0.47% | 16TCr |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- I-Mab Says FDA Grants Breakthrough Therapy Designation for Felzartamab to Treat Kidney Disease